Annual Operating Expenses
$5.09 M
-$1.22 M-19.35%
December 31, 2023
Summary
- As of February 26, 2025, LIXT annual total operating expenses is $5.09 million, with the most recent change of -$1.22 million (-19.35%) on December 31, 2023.
- During the last 3 years, LIXT annual operating expenses has risen by +$1.82 million (+55.84%).
- LIXT annual operating expenses is now -24.26% below its all-time high of $6.72 million, reached on December 31, 2021.
Performance
LIXT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$983.30 K
-$25.90 K-2.57%
September 30, 2024
Summary
- As of February 26, 2025, LIXT quarterly total operating expenses is $983.30 thousand, with the most recent change of -$25.90 thousand (-2.57%) on September 30, 2024.
- Over the past year, LIXT quarterly operating expenses has stayed the same.
- LIXT quarterly operating expenses is now -51.44% below its all-time high of $2.02 million, reached on December 31, 2021.
Performance
LIXT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LIXT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.4% | 0.0% |
| 3 y3 years | +55.8% | -41.1% |
| 5 y5 years | +138.1% | -41.1% |
LIXT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.3% | at low | -51.4% | +1.7% |
| 5 y | 5-year | -24.3% | +104.4% | -51.4% | +197.5% |
| alltime | all time | -24.3% | >+9999.0% | -51.4% | +724.3% |
Lixte Biotechnology Holdings Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $983.30 K(-2.6%) |
| Jun 2024 | - | $1.01 M(+4.4%) |
| Mar 2024 | - | $966.90 K(-5.8%) |
| Dec 2023 | $5.09 M(-19.4%) | $1.03 M(+0.2%) |
| Sep 2023 | - | $1.02 M(-38.7%) |
| Jun 2023 | - | $1.67 M(+21.9%) |
| Mar 2023 | - | $1.37 M(-16.1%) |
| Dec 2022 | $6.31 M(-6.1%) | $1.63 M(+10.4%) |
| Sep 2022 | - | $1.48 M(-4.4%) |
| Jun 2022 | - | $1.55 M(-6.6%) |
| Mar 2022 | - | $1.65 M(-18.3%) |
| Dec 2021 | $6.72 M(+105.7%) | $2.02 M(+63.6%) |
| Sep 2021 | - | $1.24 M(-28.6%) |
| Jun 2021 | - | $1.73 M(+0.4%) |
| Mar 2021 | - | $1.73 M(+90.8%) |
| Dec 2020 | $3.27 M(+31.2%) | $904.20 K(-43.5%) |
| Sep 2020 | - | $1.60 M(+329.0%) |
| Jun 2020 | - | $373.40 K(-3.6%) |
| Mar 2020 | - | $387.20 K(+17.2%) |
| Dec 2019 | $2.49 M(+16.5%) | $330.50 K(-69.8%) |
| Sep 2019 | - | $1.09 M(+74.1%) |
| Jun 2019 | - | $627.90 K(+43.1%) |
| Mar 2019 | - | $438.70 K(+24.6%) |
| Dec 2018 | $2.14 M(+18.1%) | $352.00 K(-66.0%) |
| Sep 2018 | - | $1.03 M(+178.1%) |
| Jun 2018 | - | $371.90 K(-2.1%) |
| Mar 2018 | - | $379.80 K(-12.3%) |
| Dec 2017 | $1.81 M(-15.2%) | $433.00 K(-6.5%) |
| Sep 2017 | - | $463.20 K(+58.1%) |
| Jun 2017 | - | $292.90 K(-52.8%) |
| Mar 2017 | - | $620.60 K(+20.2%) |
| Dec 2016 | $2.13 M(-25.0%) | $516.30 K(-20.2%) |
| Sep 2016 | - | $647.10 K(+16.6%) |
| Jun 2016 | - | $555.00 K(+33.2%) |
| Mar 2016 | - | $416.60 K(-48.8%) |
| Dec 2015 | $2.85 M | $813.90 K(+4.4%) |
| Sep 2015 | - | $779.70 K(+55.7%) |
| Jun 2015 | - | $500.70 K(-33.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $752.20 K(+12.5%) |
| Dec 2014 | $2.40 M(+74.8%) | $668.70 K(+33.4%) |
| Sep 2014 | - | $501.40 K(-3.1%) |
| Jun 2014 | - | $517.30 K(-27.7%) |
| Mar 2014 | - | $715.80 K(+99.4%) |
| Dec 2013 | $1.37 M(-34.7%) | $359.00 K(+14.7%) |
| Sep 2013 | - | $313.10 K(-15.1%) |
| Jun 2013 | - | $368.80 K(+10.5%) |
| Mar 2013 | - | $333.90 K(+21.1%) |
| Dec 2012 | $2.11 M(+12.7%) | $275.70 K(-67.1%) |
| Sep 2012 | - | $838.20 K(+109.5%) |
| Jun 2012 | - | $400.00 K(-32.4%) |
| Mar 2012 | - | $591.90 K(-11.7%) |
| Dec 2011 | $1.87 M(+111.9%) | $670.20 K(+34.3%) |
| Sep 2011 | - | $499.20 K(+43.5%) |
| Jun 2011 | - | $347.80 K(-0.9%) |
| Mar 2011 | - | $351.10 K(-322.9%) |
| Dec 2010 | $881.70 K(-43.1%) | -$157.50 K(-141.6%) |
| Sep 2010 | - | $378.70 K(+22.2%) |
| Jun 2010 | - | $310.00 K(-11.6%) |
| Mar 2010 | - | $350.50 K(-39.0%) |
| Dec 2009 | $1.55 M(+21.7%) | $575.00 K(+26.9%) |
| Sep 2009 | - | $453.10 K(+86.5%) |
| Jun 2009 | - | $243.00 K(-12.9%) |
| Mar 2009 | - | $279.10 K(+7.1%) |
| Dec 2008 | $1.27 M(-23.2%) | $260.60 K(-47.5%) |
| Sep 2008 | - | $496.50 K(+4413.6%) |
| Jun 2008 | - | $11.00 K(-97.8%) |
| Mar 2008 | - | $505.40 K(+68.4%) |
| Dec 2007 | $1.66 M(+268.7%) | $300.10 K(-67.4%) |
| Sep 2007 | - | $921.80 K(+414.1%) |
| Jun 2007 | - | $179.30 K(-30.4%) |
| Mar 2007 | - | $257.80 K(+73.7%) |
| Dec 2006 | $450.00 K(+1267.8%) | $148.40 K(+28.5%) |
| Sep 2006 | - | $115.50 K(-29.6%) |
| Jun 2006 | - | $164.00 K(+642.1%) |
| Mar 2006 | - | $22.10 K |
| Dec 2005 | $32.90 K | - |
FAQ
- What is Lixte Biotechnology Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual operating expenses year-on-year change?
- What is Lixte Biotechnology Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings quarterly operating expenses year-on-year change?
What is Lixte Biotechnology Holdings annual total operating expenses?
The current annual operating expenses of LIXT is $5.09 M
What is the all time high annual operating expenses for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual total operating expenses is $6.72 M
What is Lixte Biotechnology Holdings annual operating expenses year-on-year change?
Over the past year, LIXT annual total operating expenses has changed by -$1.22 M (-19.35%)
What is Lixte Biotechnology Holdings quarterly total operating expenses?
The current quarterly operating expenses of LIXT is $983.30 K
What is the all time high quarterly operating expenses for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly total operating expenses is $2.02 M
What is Lixte Biotechnology Holdings quarterly operating expenses year-on-year change?
Over the past year, LIXT quarterly total operating expenses has changed by $0.00 (0.00%)